181 related articles for article (PubMed ID: 36879039)
21. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
22. Development and Characterization of
Bolzati C; Gobbi C; Ferro-Flores G; Turato S; Ocampo-Garcia B; Carpanese D; Marzano C; Spolaore B; Fracasso G; Rosato A; Meléndez-Alafort L
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203663
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive Radionuclide Molecular Imaging of the CD4-Positive T Lymphocytes in Acute Cardiac Rejection.
Li H; Chen Y; Jin Q; Wu Y; Deng C; Gai Y; Sun Z; Li Y; Wang J; Yang Y; Lv Q; Zhang Y; An R; Lan X; Zhang L; Xie M
Mol Pharm; 2021 Mar; 18(3):1317-1326. PubMed ID: 33506680
[TBL] [Abstract][Full Text] [Related]
24. SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.
Li F; Zhang Z; Cheng T; Wei R; Dai Y; Lv M; Luo D; Zhu X; Ma D; Xi L; Dong Q; Ma X
Amino Acids; 2016 Jan; 48(1):91-101. PubMed ID: 26255282
[TBL] [Abstract][Full Text] [Related]
25. Preliminary application of micro-SPECT/CT imaging by
Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
[TBL] [Abstract][Full Text] [Related]
26. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a New
Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
[TBL] [Abstract][Full Text] [Related]
28. Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
van der Geest T; Laverman P; Gerrits D; Walgreen B; Helsen MM; Klein C; Nayak TK; Storm G; Metselaar JM; Koenders MI; Boerman OC
J Nucl Med; 2017 Jan; 58(1):151-155. PubMed ID: 27493266
[TBL] [Abstract][Full Text] [Related]
29. A Pretargeted Imaging Strategy for EGFR-Positive Colorectal Carcinoma via Modulation of Tz-Radioligand Pharmacokinetics.
Qiu L; Lin Q; Si Z; Tan H; Liu G; Zhou J; Wang T; Chen Y; Huang Y; Yu T; Jin M; Cheng D; Shi H
Mol Imaging Biol; 2021 Feb; 23(1):38-51. PubMed ID: 32914391
[TBL] [Abstract][Full Text] [Related]
30. Development of
Ye Q; Liu Z; Zhang S; Wang G; Wen G; Dong M
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765712
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Evaluation of
Ruan Q; Wang Q; Jiang Y; Feng J; Yin G; Zhang J
J Med Chem; 2023 Apr; 66(7):4952-4960. PubMed ID: 36972467
[TBL] [Abstract][Full Text] [Related]
32. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
33. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics.
Wen X; Xu P; Shi M; Liu J; Zeng X; Zhang Y; Shi C; Li J; Guo Z; Zhang X; Khong PL; Chen X
Theranostics; 2022; 12(1):422-433. PubMed ID: 34987657
[No Abstract] [Full Text] [Related]
34. [
Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive Imaging of Tumor PD-L1 Expression Using [
Zhang Y; Ding Y; Li N; Wang S; Zhou S; Li R; Yang H; Li W; Qu J
Mol Pharm; 2023 Jan; 20(1):690-700. PubMed ID: 36541699
[TBL] [Abstract][Full Text] [Related]
36. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Preclinical Evaluation of Novel
Ruan Q; Ding D; Diao L; Feng J; Yin G; Jiang Y; Wang Q; Han P; Jiang J; Zhang J
J Med Chem; 2024 Feb; 67(4):3190-3202. PubMed ID: 38320123
[TBL] [Abstract][Full Text] [Related]
38. Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy.
Li Y; Hu Y; Xiao J; Liu G; Li X; Zhao Y; Tan H; Shi H; Cheng D
Sci Rep; 2016 Sep; 6():33511. PubMed ID: 27649935
[TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of
Maleki F; Masteri Farahani A; Sadeghzadeh N; Mardanshahi A; Abediankenari S
Chem Biol Drug Des; 2020 Nov; 96(5):1223-1231. PubMed ID: 32426902
[TBL] [Abstract][Full Text] [Related]
40. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]